TrianglePUBLICATIONS · 21967976
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2011 Dec 1
- First author
- Hijiya N
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Hijiya N
- type
- Author
- name
- Thomson B
- type
- Author
- name
- Isakoff MS
- type
- Author
- name
- Silverman LB
- type
- Author
- name
- Steinherz PG
- type
- Author
- name
- Borowitz MJ
- type
- Author
- name
- Kadota R
- type
- Author
- name
- Cooper T
- type
- Author
- name
- Shen V
- type
- Author
- name
- Dahl G
- type
- Author
- name
- Thottassery JV
- type
- Author
- name
- Jeha S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Hijiya N
- type
- Author
- name
- Thomson B
- type
- Author
- name
- Isakoff MS
- type
- Author
- name
- Silverman LB
- type
- Author
- name
- Steinherz PG
- type
- Author
- name
- Borowitz MJ
- type
- Author
- name
- Kadota R
- type
- Author
- name
- Cooper T
- type
- Author
- name
- Shen V
- type
- Author
- name
- Dahl G
- type
- Author
- name
- Thottassery JV
- type
- Author
- name
- Jeha S
- type
- Author
- bibliography ids
- nci-bib-8855d0494663d484dabfe67c
- book metadata
- content sha256
- c906bb8b493bff7119c75e9f832062423d5948ea53800e2a7798717a4ec2f425
- document type
- citation
- dois
- 10.1182/blood-2011-08-374710
- electronic publication date
- display
- 2011 Oct 3
- precision
- day
- year
- 2011
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:21967976
- immutable id
- pubmed:21967976@c906bb8b493bff7119c75e9f832062423d5948ea53800e2a7798717a4ec2f425
- journal
- abbreviation
- Blood
- issn electronic
- 1528-0020
- issn print
- 0006-4971
- issue
- 23
- name
- Blood
- nlm unique id
- 7603509
- pages
- 6043-9
- volume
- 118
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 21967976
- provenance
- batch id
- 2529ef2eca926738ab13
- provider
- NCBI PubMed ESummary
- record sha256
- f1a6ebed68f1759ed9459726f7093186802460545176b6be7d233b790ff63af1
- response sha256
- 9204e3dd8d67df5a6773613a8059d8d42d9842ee24eecc9b0f39a62f636c99b6
- retrieved at
- 2026-09-09T23:46:42.856296+00:00
- publication date
- display
- 2011 Dec 1
- precision
- day
- year
- 2011
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
Preserved source evidence · Not medical advice